{"resourceType": "Evidence", "meta": {"versionId": "10", "lastUpdated": "2025-08-12T18:25:29.662Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence"]}, "title": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "status": "active", "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000457", "display": "difference in means"}]}, "quantity": {"value": -4.5, "unit": "mm Hg"}, "sampleSize": {"numberOfParticipants": 62, "knownDataCount": 53, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed", "valueUnsignedInt": 60}]}, "attributeEstimate": [{"type": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000196", "display": "confidence interval"}]}, "level": 0.95, "range": {"low": {"value": -10.82, "unit": "mm Hg"}, "high": {"value": 1.32, "unit": "mm Hg"}}}, {"type": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000700", "display": "p-value"}]}, "quantity": {"value": 0.123}}]}], "relatesTo": [{"type": "part-of", "targetReference": {"reference": "Composition/375280", "type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial"}}], "variableDefinition": [{"variableRole": "population", "observed": {"reference": "EvidenceVariable/375183", "type": "EvidenceVariable", "display": "GroupAssignment: Quadpill vs. Candesartan"}}, {"variableRole": "outcome", "observed": {"reference": "EvidenceVariable/375185", "type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks"}}], "url": "https://fevir.net/resources/Evidence/375907", "id": "375907", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "375907", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Joanne Dehnbostel"}], "citeAs": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375907. Revised 2025-08-12. Available at: https://fevir.net/resources/Evidence/375907. Computable resource at: https://fevir.net/resources/Evidence/375907#json.", "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "name": "Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan", "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}